The University of Chicago Header Logo

A phase 2 trial of inhaled nitrous oxide for treatment-resistant major depression.

A phase 2 trial of inhaled nitrous oxide for treatment-resistant major depression. Sci Transl Med. 2021 06 09; 13(597).

View in: PubMed